ARTICLE | Clinical News
rhBMP-2/ACS regulatory update
February 26, 2001 8:00 AM UTC
The FDA accepted for filing AHP's PMA for its rhBMP-2/ACS, a combination of recombinant human Bone Morphogenic Protein-2 (rhBMP-2) and Absorbable Collagen Sponge (ACS) matrix, to treat acute long-bon...